Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial.

Tsermoulas G, Mollan SP, Homer V, Kristunas C, White P, Wakerley BR, Toma AK, Robertson F, Berman G, Ahmed F, Atan D, Bandyopadhyay S, Barton D, Booth T, Bremner F, Denton A, Downer J, Edwards R, Frew E, Gew JJY, Hill LJ, Hughes T, Lax S, Macdonald J, Maxwell G, McHugh J, Shah P, Taleti E, Tasker R, Thomas S, Joannides AJ, Sinclair A

Open source

DOI
10.1136/bmjopen-2025-111013
Published
2026 Aug 3
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2025-111013,
  title = {Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial.},
  author = {Tsermoulas G and Mollan SP and Homer V and Kristunas C and White P and Wakerley BR and Toma AK and Robertson F and Berman G and Ahmed F and Atan D and Bandyopadhyay S and Barton D and Booth T and Bremner F and Denton A and Downer J and Edwards R and Frew E and Gew JJY and Hill LJ and Hughes T and Lax S and Macdonald J and Maxwell G and McHugh J and Shah P and Taleti E and Tasker R and Thomas S and Joannides AJ and Sinclair A},
  year = {2026},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2025-111013},
  url = {https://doi.org/10.1136/bmjopen-2025-111013}
}

RIS

TY  - JOUR
TI  - Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial.
AU  - Tsermoulas G
AU  - Mollan SP
AU  - Homer V
AU  - Kristunas C
AU  - White P
AU  - Wakerley BR
AU  - Toma AK
AU  - Robertson F
AU  - Berman G
AU  - Ahmed F
AU  - Atan D
AU  - Bandyopadhyay S
AU  - Barton D
AU  - Booth T
AU  - Bremner F
AU  - Denton A
AU  - Downer J
AU  - Edwards R
AU  - Frew E
AU  - Gew JJY
AU  - Hill LJ
AU  - Hughes T
AU  - Lax S
AU  - Macdonald J
AU  - Maxwell G
AU  - McHugh J
AU  - Shah P
AU  - Taleti E
AU  - Tasker R
AU  - Thomas S
AU  - Joannides AJ
AU  - Sinclair A
PY  - 2026
JO  - BMJ open
DO  - 10.1136/bmjopen-2025-111013
UR  - https://doi.org/10.1136/bmjopen-2025-111013
ER  - 

APA

G, T., SP, M., V, H., C, K., P, W., BR, W., AK, T., F, R., G, B., F, A., D, A., S, B., D, B., T, B., F, B., A, D., J, D., R, E., E, F., JJY, G., LJ, H., T, H., S, L., J, M., G, M., J, M., P, S., E, T., R, T., S, T., AJ, J., & A, S. (2026). Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial.. BMJ open. https://doi.org/10.1136/bmjopen-2025-111013

Source records